Diagnostic test values for the prediction of mutations in NPM1, CEBP· and MLL-PTD for the independent validation cohort by the gene expression signature consisting of 45 probe sets (A) and for the prediction of type I molecular subtypes for the independent validation cohort by the gene expression signature consisting of 30 probe sets (B).